European Archives - Page 1071 of 1425 - European Medical Journal

World COPD Day: This Year’s Campaign and Trends in the Field

Chronic obstructive pulmonary disease (COPD) is highly prevalent throughout the world and a major cause of mortality, with 5% of all global deaths…

Air Pollution and Asthma

Air pollution, caused by cars and other pollutants, has long been linked to asthma attacks. A new study, conducted at the Milken Institute School of…

Drug-induced interstitial lung disease

Drug-induced interstitial lung disease (DIILD) causes breathing difficulties, pulmonary fibrosis, and inflammation. It is diagnosed in 4.1–12.4 million…

An interview with Philippe Kirby from MSD

An interview with Philippe Kirby, Customer Engagement Capabilities Director, MSD, at the eyeforpharma Marketing and Customer Innovation, Europe. Kirby discusses the power of data and digital in delivering a personalised customer experience as well as what inspires him within and outside the industry.

EMJ Dermatology Review 2018

This spectacular dermatology review features a myriad of exclusive EMJ symposium and poster reviews detailing the latest updates and trial results from…

The Big Beat Challenge and the British Heart Foundation’s (BHF) Emphasis on Collaboration

The British Heart Foundation (BHF) unveiled a major new research initiative during the recent European Society of Cardiology (ESC) Congress, which was…

Novel Genomic Scoring System Could Revolutionise Coronary Artery Disease Stratification

An innovative genomic scoring system, metaGRS, is proving effective at stratifying coronary artery disease (CAD) patients, according to results from a…

Improving on the Mediterranean Diet: The Benefits of Seed Oils

Replacing food rich in saturated fats, such as butter or lard, with those rich in unsaturated fats, such as olive oil, has long been known to reduce…

European Medical Journal Presents: EMJ Respiratory 6.1

The European Medical Journal has published the latest edition of the EMJ Respiratory eJournal, which includes a comprehensive review…

Assessment of Efficacy of Omalizumab Retreatment in Patients With Severe Asthma

Omalizumab is a recombinant humanised monoclonal anti-IgE antibody currently approved in the USA and Europe for treating inadequately controlled allergic…